1353. In Vitro Activity of Lefamulin (LEF) Against Bacterial Pathogens Commonly Causing Community-Acquired Bacterial Pneumonia (CABP): 2016 SENTRY Data From the United States

por Paukner, Susanne, Flamm, Robert K, Gelone, Steven P, Sader, Helio S
Publicado 2018

1365. In Vitro Activity of Lefamulin (LEF) Against Bacterial Pathogens Causing Community-Acquired Bacterial Pneumonia (CABP): SENTRY Surveillance 2016 Results From Asia-Pacific (AP...

por Paukner, Susanne, Flamm, Robert K, Gelone, Steven P, Sader, Helio S
Publicado 2018

703. In Vitro Activity of Lefamulin Against Bacterial Pathogens Causing Community-Acquired Bacterial Pneumonia (CABP): SENTRY Surveillance 2017–2018 Results From the United States...

por Sader, Helio S, Paukner, Susanne, Arends, S J Ryan, Gelone, Steven P
Publicado 2019

A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant S. pneumoniae in Ambulatory and Hospitalized Adult Patients in the United States

por Gupta, Vikas, Yu, Kalvin C, Schranz, Jennifer, Gelone, Steven P
Publicado 2021

Tissue Distribution of [(14)C]-Lefamulin into the Urogenital Tract in Rats

por Wicha, Wolfgang W., Henson, Claire, Webbley, Kathryn, Gelone, Steven P.
Publicado 2022

In Vitro Activity of Lefamulin against S. aureus Collected Worldwide from Hospitalized Patients with Bacterial Pneumonia

por Paukner, Susanne, Flamm, Robert K, Schuchert, Jason, Gelone, Steven P, Sader, Helio S
Publicado 2017

Pharmacokinetics and tolerability of lefamulin following intravenous and oral dosing

por Wicha, Wolfgang W, Prince, William T, Lell, Claudia, Heilmayer, Werner, Gelone, Steven P
Publicado 2019

684. Cardiac Safety in Adults with Community-Acquired Bacterial Pneumonia (CABP) Treated with Lefamulin (LEF) or Moxifloxacin (MOX): Analysis of Lefamulin Evaluation Against Pneumo...

por Darpo, Borje, Das, Anita F, Stein, Daniel, Schranz, Jennifer, Gelone, Steven P
Publicado 2019

In Vitro Activity of Lefamulin Against a Global Collection of Bacterial Pathogens Commonly Causing Community-Acquired Bacterial Pneumonia (CABP, SENTRY 2015)

por Paukner, Susanne, Sader, Helio S, Streit, Jennifer M, Flamm, Robert K, Gelone, Steven P
Publicado 2017

699. Hepatobiliary Safety in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation A...

por Lewis, James H, Das, Anita F, Stein, Daniel, Gelone, Steven P, Schranz, Jennifer
Publicado 2019

1320. In Vitro Activity of Lefamulin against Staphylococcus aureus Isolated from the Lower Respiratory Tract of Children with Cystic Fibrosis

por Sader, Helio S, Paukner, Susanne, Gelone, Steven P, Arends, S J Ryan, Mendes, Rodrigo E
Publicado 2021

Anti-inflammatory activity of lefamulin versus azithromycin and dexamethasone in vivo and in vitro in a lipopolysaccharide-induced lung neutrophilia mouse model

por Hafner, Michael, Paukner, Susanne, Wicha, Wolfgang W., Hrvačić, Boška, Cedilak, Matea, Faraho, Ivan, Gelone, Steven P.
Publicado 2021

1485. Trends in Important-Resistant Gram-Negative (GN) and Gram-Positive (GP) Urine Bacterial Pathogens in Hospitalized Patients in the United States: A Multicenter Evaluation from...

por Lodise, Thomas, Gelone, Steven P, Yu, Kalvin, Gupta, Kalpana, Early, Maureen, Ye, Gang, Schranz, Jennifer, Gupta, Vikas
Publicado 2019

1440. Prevalence and Regional Variation of in ESBLs and CRE Enterobacteriaceae (ENT) among Adult, Hospitalized Patients with ENT on a Urine Culture: A Multicenter Evaluation

por Lodise, Thomas, Gupta, Vikas, Yu, Kalvin, Gupta, Kalpana, Early, Maureen, Ye, Gang, Schranz, Jennifer, Gelone, Steven P
Publicado 2019

705. Pharmacokinetics (PK) and Safety of Lefamulin (LEF) After Single Intravenous Dose Administration in Subjects With Impaired Renal Function and in Those Requiring Hemodialysis

por Wicha, Wolfgang, Marbury, Thomas C, Dowell, James A, Lykens, Lori, Leister, Cathie, Ermer, James, Gelone, Steven P
Publicado 2019

722. Pharmacokinetics (PK) and Safety of Lefamulin (LEF) After Single Intravenous Dose Administration in Subjects With Impaired Hepatic Function

por Wicha, Wolfgang, Marbury, Thomas C, Dowell, James A, Lykens, Lori, Leister, Cathie, Ermer, James, Gelone, Steven P
Publicado 2019

720. Efficacy of Fosfomycin for Injection (FOS) vs. Piperacillin–Tazobactam (PIP-TAZ) in Adults with Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP): ZEUS...

por Kaye, Keith S, Das, Anita F, Eckburg, Paul B, Gelone, Steven P, Schranz, Jennifer, Ellis-Grosse, Evelyn J
Publicado 2019

2245. Oral 5-Day Lefamulin for Outpatient Management of Pneumonia Outcomes Research Team (PORT) Risk Class III/IV Community-Acquired Bacterial Pneumonia (CABP): Post Hoc Analysis o...

por Schranz, Jennifer, Alexander, Elizabeth, Fitts, David, Mariano, David, Meads, Andrew, Sandrock, Christian, Moran, Gregory J, Gelone, Steven P
Publicado 2019

2233. Efficacy and Symptom Resolution by Visit in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of L...

por Schranz, Jennifer, Das, Anita F, Alexander, Elizabeth, Moran, Gregory J, Sandrock, Christian, File, Thomas M, Gelone, Steven P
Publicado 2019

664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled A...

por Alexander, Elizabeth, Schranz, Jennifer, Das, Anita F, Moran, Gregory J, Sandrock, Christian, File, Thomas M, Gelone, Steven P
Publicado 2019